This concept refers to α-synuclein assembling into multiple conformationally distinct fibril forms in vitro and in vivo. The review presents these polymorphs as structurally and functionally relevant variants.
First-pass extracted concept
α-synuclein fibril polymorphism
Extracted Explainers
What the tool is doing
What problem it solves
What it does not solve
Evidence Snippets
Supporting Sources
Linked Claims
Diverse α-synuclein molecular polymorphs contribute to clinical heterogeneity in synucleinopathies.
Aggregated α-synuclein accumulates in multiple neurodegenerative diseases including PD, MSA, DLB, PDD, and some AD cases with Lewy-body-like pathology.
α-synuclein polymorphs from the same precursor protein may have strain-specific biochemical properties and may induce distinct pathological phenotypes when inoculated in animal models.
α-synuclein self-assembles into conformationally diverse polymorphs in vitro and in vivo.
Recent advances in high-resolution structures and brain-derived strains are being used to delineate relationships between α-synuclein structure and pathogenicity.